about
Animal models of systemic sclerosis: their utility and limitations.Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.A unifying hypothesis for scleroderma: identifying a target cell for scleroderma.Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based studyVasculitis in systemic sclerosis.ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.Cardiovascular disease in systemic sclerosis.Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial-mesenchymal transition in vitroThe risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.Interferon-γ promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) β2.Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases.Peripheral neuropathy: a complication of systemic sclerosis.Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine.The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
P2860
Q28390528-D496C8D0-88AD-43A1-A49A-E86257606FDCQ33588440-27421462-1FD7-4323-AE77-9BA182CAB43CQ33889221-B2FA8AAD-FEF7-4D12-8072-E9E837A47B97Q34022581-3D2C6B96-E6C2-4D63-A449-BCED7A561BC5Q34189036-71B25C4B-0985-47BF-B52F-9078B550DA21Q34354002-2742D6FB-C868-482E-9FEE-0CC55858E8C2Q34947193-4788C787-A6F3-414A-B2BA-51297EF2BB1CQ35047990-30F44173-658E-4A99-BCD8-6F663062ACBCQ35100214-8B1E7DB5-1D7D-45A1-90AB-54139A583B40Q35283742-B379ED7A-3161-498C-A01B-35854B50B59EQ35387131-C10B6F30-8A7C-4C4F-AD88-84EA7C6BE30BQ37555367-D63DD349-6435-4363-9098-F8576EF484FCQ39966988-5209AE9C-1406-44F0-BB93-C94F6A47FB13Q41252594-26FACB5A-E02C-4E0A-87A5-BFA06A00C67CQ50935068-5210C1E1-9A5A-465C-92A6-4C8EE20D4531Q53114309-8517CA6F-5515-482F-B78E-015A7D812811Q54271815-52409E5C-2ADE-4CB6-98FF-7C91D5DC057FQ58705720-B2AAA48A-2446-4262-9D0F-8E11368BF1FD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is scleroderma a vasculopathy?
@en
Is scleroderma a vasculopathy?
@nl
type
label
Is scleroderma a vasculopathy?
@en
Is scleroderma a vasculopathy?
@nl
prefLabel
Is scleroderma a vasculopathy?
@en
Is scleroderma a vasculopathy?
@nl
P2093
P2860
P1476
Is scleroderma a vasculopathy?
@en
P2093
Jo Nadine Fleming
Richard A Nash
Stephen Mark Schwartz
William M Mahoney
P2860
P2888
P304
P356
10.1007/S11926-009-0015-3
P577
2009-04-01T00:00:00Z